Francesco Marass
Papers
1
Total Citations
109
H-Index
1
About
Francesco Marass is a leading researcher in liquid biopsy and noninvasive cancer diagnostics, with a focus on circulating tumor DNA (ctDNA) analysis. His work addresses critical pre-analytical challenges that underpin the reliability of ctDNA detection in plasma, a field essential for advancing personalized oncology. In his highly cited 2018 study (109 citations), Marass systematically investigated how collection and processing procedures influence plasma cell-free DNA (cfDNA) levels, demonstrating that leukocyte lysis during sample handling can significantly confound ctDNA measurements. This contribution has been instrumental in establishing standardized protocols for liquid biopsy, improving the accuracy of noninvasive cancer monitoring. By clarifying the impact of pre-analytical variables, Marass has helped bridge the gap between research and clinical application, enabling more robust detection of minimal residual disease and treatment response. His work is widely referenced by both academic groups and diagnostic developers, reflecting its foundational role in the field. Marass continues to drive innovation in cfDNA methodologies, shaping best practices for liquid biopsy in oncology.
Research Focus
Key Achievements
Top Papers
- 1